Prelude Capital Management, LLC Neuronetics, Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.73 - $4.81 $532 - $1,481	-308 Reduced 0.66%	46,219 $83,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $124,692 - $223,329	46,527 New	46,527 $221,000
Q2 2023 Aug 14, 2023	SELL	$2.07 - $2.92 $41,927 - $59,144	-20,255 Reduced 11.19%	160,808 $345,000
Q1 2023 May 15, 2023	SELL	$2.81 - $6.71 $237,574 - $567,303	-84,546 Reduced 31.83%	181,063 $526,000
Q4 2022 Feb 14, 2023	SELL	$2.74 - $6.87 $87,164 - $218,548	-31,812 Reduced 10.7%	265,609 $1.82 Million
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $4,465 - $8,854	-1,900 Reduced 0.63%	297,421 $946,000
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $36,069 - $64,027	17,258 Added 6.12%	299,321 $961,000
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $34,258 - $54,524	12,063 Added 4.47%	282,063 $855,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $175,357 - $298,606	45,312 Added 20.17%	270,000 $1.2 Million
Q3 2021 Nov 15, 2021	BUY	$6.22 - $15.54 $569,036 - $1.42 Million	91,485 Added 68.68%	224,688 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $1.35 Million - $2.3 Million	133,203 New	133,203 $2.13 Million
Q4 2020 Feb 16, 2021	SELL	$4.95 - $11.45 $178,596 - $413,116	-36,080 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.82 - $5.87 $65,210 - $210,322	35,830 Added 14332.0%	36,080 $175,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $2.61 $352 - $652	250 New	250 $0
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $39,091 - $89,434	-9,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $76,294 - $119,628	9,181 Added 1768.98%	9,700 $81,000
Q2 2019 Aug 14, 2019	BUY	$9.0 - $17.2 $4,671 - $8,926	519 New	519 $6,000
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $334,592 - $665,838	-20,912 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $119,459 - $184,396	4,912 Added 30.7%	20,912 $670,000
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $425,760 - $444,480	16,000 New	16,000 $426,000

Others Institutions Holding STIM

# of Institutions

Shares Held

13M

Call Options Held

30.1K

Put Options Held

Kent Lake Pr LLC Anasco, PR

2.08M
Shares

$4.92 Million
0.63% of portfolio
Kent Lake Capital LLC Mill Valley, CA

1.74M
Shares

$4.12 Million
1.44% of portfolio
Cannell Capital LLC Alta, WY

1.31M
Shares

$3.11 Million
0.23% of portfolio
Vanguard Group Inc Valley Forge, PA

1.3M
Shares

$3.08 Million
0.0% of portfolio
Masters Capital Management LLC Atlanta, GA

1.2M
Shares

$2.84 Million
0.05% of portfolio

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $64M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account